
Keywords: ACPA; anti-citrullinated protein antibody; CCP; cyclic citrullinated peptide; CII; type II collagen; COX-2; cyclooxygenase-2 (also known as prostaglandin H synthase-2); CV; column volume; DMARD; disease-modifying antirheumatic drug; ELISA; enzyme-linked i